hereditary nonpolyposis colorectal cancer

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:secondary_glioblastoma
gptkbp:associated_with gptkb:healthcare_organization
gptkb:Lynch_syndrome
gptkb:bile_duct_cancer
ovarian cancer
stomach cancer
brain tumors
other cancers
small intestine cancer
urinary tract cancer
sebaceous gland tumors
gptkbp:descendant autosomal dominant
gptkbp:first_described_by gptkb:1993
gptkbp:genetic_diversity ML H1, MS H2, MS H6, PM S2
mutations in mismatch repair genes
https://www.w3.org/2000/01/rdf-schema#label hereditary nonpolyposis colorectal cancer
gptkbp:is_popular_in 1 in 300
gptkbp:is_protected_by lifestyle changes
regular screening
gptkbp:lifespan up to 10% for stomach cancer
up to 15% for ovarian cancer
up to 5% for bile duct cancer
up to 5% for brain tumors
up to 5% for pancreatic cancer
up to 5% for sebaceous gland tumors
up to 5% for skin cancer
up to 5% for small intestine cancer
up to 5% for urinary tract cancer
up to 60% for endometrial cancer
up to 80% for colorectal cancer
gptkbp:provides_information_on gptkb:American_College_of_Gastroenterology
gptkb:European_Society_for_Medical_Oncology
gptkb:American_Society_of_Clinical_Oncology
gptkb:National_Comprehensive_Cancer_Network
Society of Surgical Oncology
gptkbp:research_focus patient education
early detection
genetic counseling
family planning
treatment options
gptkbp:risk_factor family history
gptkbp:screenings beginning at age 20-25
gptkbp:social_responsibility genetic testing
gptkbp:symptoms endometrial cancer
colorectal tumors
gptkbp:treatment gptkb:hospital
radiation therapy
chemotherapy